For years, America’s leading retailers have benefited from a little-known program that helps to resolve meritless patent disputes, called Inter Partes Review. Congress created the IPR process in 2012 ...
An expert Q&A on the US Patent and Trademark Office’s (USPTO’s) 2025 guidance memoranda addressing the Patent Trial and Appeal Board’s (PTAB’s) approach to discretionary denials of inter partes review ...
While there's no definitive consensus, economists are closely monitoring the possibility of entering a recession this year. Economists agree a recession is not imminent, but caution the odds of facing ...
Moderna will pay up to $2.25B to settle a patent lawsuit over lipid nanoparticle technology used in its COVID-19 vaccine.
The Rise of ‘Settled Expectations’ In USPTO Review and the Fallout for Patent Owners and Challengers
The landscape for discretionary denials at PTAB is evolving quickly; both patent challengers and owners must adapt their strategies to ensure they are not left behind by the USPTO’s new approach. The ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
"seven patents covering hybrid bonding technology and three patents covering advanced process node technology." How does a lawsuit like this even work when AMD does ...
“The CAFC said the district court found ‘the ’091 patent was ‘demonstrably weak on its face, despite the initial presumptions created when the patent was issued by the PTO.’” The U.S. Court of Appeals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results